Pharma Deutschland regional board discusses industry regulation in Bavaria
The board of the Bavarian division of Pharma Deutschland met at Salus Haus to address policy developments and the impact of upcoming EU wastewater regulations.
The regional board of Pharma Deutschland in Bavaria held a meeting at the offices of Salus Haus Dr. med. Otto Greither to assess the current political landscape for the pharmaceutical industry. The discussions focused on both regional and national policy developments affecting sector operations.
A primary concern addressed during the meeting was the potential impact of the new EU wastewater directive on pharmaceutical manufacturing. As environmental regulations tighten, industry leaders are evaluating the technical and financial implications of compliance within their production facilities.
In addition to regulatory matters, the board reviewed strategies to enhance the industry's influence through upcoming networking events in Bavaria. These initiatives are designed to improve communication between pharmaceutical companies and policy stakeholders in the region.